Abbott Laboratories

ABTHealthcare

Sentinellis Health Score

10/10

Financially healthy
Market Cap

$154.7B

Revenue

$44.3B

P/E Ratio

24.9x

AI Summary

Abbott makes and sells healthcare products worldwide across four main areas: generic pharmaceuticals for chronic conditions, laboratory diagnostic systems and rapid tests, infant formula and nutritional products for children and adults, and medical devices including heart valves, glucose monitors, and pacemakers [Yahoo Finance]. The company serves hospitals, clinics, pharmacies, and consumers in both developed and emerging markets.

Abbott Laboratories is a diversified healthcare giant operating across four major segments: established pharmaceuticals, diagnostic products, nutritional products, and medical devices [Yahoo Finance]. The company generates $44.3B in annual revenue with strong margins and minimal debt, earning a perfect 10.0/10 financial health score [Yahoo Finance]. Recent strategic moves include a $21B acquisition of cancer diagnostics firm Exact Sciences and a pivot toward volume-driven nutrition sales, though the nutrition division contracted 6% in early 2026 [Yahoo Finance].

Abbott maintains exceptionally strong financial health with minimal debt, robust cash generation, and consistent profitability.

Confidence8/10

Recent News

  • Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum

    Yahoo Finance· 2026-05-20
  • ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?

    Yahoo Finance· 2026-05-18
  • Abbott Laboratories Insiders Added US$4.23m Of Stock To Their Holdings

    Yahoo Finance· 2026-05-19
  • Kernicterus Market Research and Forecast Report 2026-2036 Featuring Pfizer, F.Hoffmann La Roche,. Merck, AbbVie, AsteraZeneca, Abbott Laboratories, Sanofi, GlaxoSmithKline, Grifols

    Yahoo Finance· 2026-05-18
  • Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

    Yahoo Finance· 2026-05-18
  • Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo

    Yahoo Finance· 2026-05-18

Risk Analysis

Opportunities

Full Financials

Executive Team

Unlock the full Abbott Laboratories analysis

Create a free account to access the complete AI-generated report with inline citations.

  • Risks, opportunities, and red flags with sources
  • 100+ financial metrics with charts and benchmarks
  • Full news summaries with source links
  • Executive team and compensation details
  • PDF export for offline use
Get my free report3 free reports · No credit card

Other companies you might find interesting

Same sector (Healthcare) or comparable health.